Works by Gough, Peter J.


Results: 18
    1

    LUBAC prevents lethal dermatitis by inhibiting cell death induced by TNF, TRAIL and CD95L.

    Published in:
    Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06155-8
    By:
    • Taraborrelli, Lucia;
    • Peltzer, Nieves;
    • Montinaro, Antonella;
    • Kupka, Sebastian;
    • Rieser, Eva;
    • Hartwig, Torsten;
    • Sarr, Aida;
    • Darding, Maurice;
    • Draber, Peter;
    • Haas, Tobias L.;
    • Akarca, Ayse;
    • Marafioti, Teresa;
    • Pasparakis, Manolis;
    • Bertin, John;
    • Gough, Peter J.;
    • Bouillet, Philippe;
    • Strasser, Andreas;
    • Leverkus, Martin;
    • Silke, John;
    • Walczak, Henning
    Publication type:
    Article
    2
    3

    RIPK1 protects from TNF-α-mediated liver damage during hepatitis.

    Published in:
    Cell Death & Disease, 2016, v. 7, n. 11, p. e2462, doi. 10.1038/cddis.2016.362
    By:
    • Filliol, Aveline;
    • Piquet-Pellorce, Claire;
    • Le Seyec, Jacques;
    • Farooq, Muhammad;
    • Genet, Valentine;
    • Lucas-Clerc, Catherine;
    • Bertin, John;
    • Gough, Peter J;
    • Dimanche-Boitrel, Marie-Thérèse;
    • Vandenabeele, Peter;
    • Bertrand, Mathieu JM;
    • Samson, Michel
    Publication type:
    Article
    4
    5
    6
    7

    RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis.

    Published in:
    Nature, 2014, v. 513, n. 7516, p. 95, doi. 10.1038/nature13706
    By:
    • Takahashi, Nozomi;
    • Vereecke, Lars;
    • Bertrand, Mathieu J. M.;
    • Duprez, Linde;
    • Divert, Tatyana;
    • Sze, Mozes;
    • Gilbert, Barbara;
    • Kourula, Stephanie;
    • Goossens, Vera;
    • Lefebvre, Sylvie;
    • Declercq, Wim;
    • van Loo, Geert;
    • Berger, Scott B.;
    • Bertin, John;
    • Gough, Peter J.;
    • Gonçalves, Amanda;
    • Günther, Claudia;
    • Becker, Christoph;
    • Vandenabeele, Peter
    Publication type:
    Article
    8
    9

    Identification of an antibody-based immunoassay for measuring direct target binding of RIPK1 inhibitors in cells and tissues.

    Published in:
    Pharmacology Research & Perspectives, 2017, v. 5, n. 6, p. 1, doi. 10.1002/prp2.377
    By:
    • Finger, Joshua N.;
    • Brusq, Jean‐Marie;
    • Campobasso, Nino;
    • Cook, Michael N.;
    • Deutsch, Jennifer;
    • Haag, Heather;
    • Harris, Philip A.;
    • Jenkins, Earl L.;
    • Joglekar, Devika;
    • Lich, John D.;
    • Maguire, Sean;
    • Nagilla, Rakesh;
    • Rivera, Elizabeth J.;
    • Sun, Helen;
    • Votta, Bartholomew J.;
    • Bertin, John;
    • Gough, Peter J.
    Publication type:
    Article
    10

    Randomized clinical study of safety, pharmacokinetics, and pharmacodynamics of RIPK1 inhibitor GSK2982772 in healthy volunteers.

    Published in:
    Pharmacology Research & Perspectives, 2017, v. 5, n. 6, p. 1, doi. 10.1002/prp2.365
    By:
    • Weisel, Kathleen;
    • Scott, Nicola E.;
    • Tompson, Debra J.;
    • Votta, Bartholomew J.;
    • Madhavan, Sujith;
    • Povey, Kat;
    • Wolstenholme, Allen;
    • Simeoni, Monica;
    • Rudo, Todd;
    • Richards‐Peterson, Lauren;
    • Sahota, Tarjinder;
    • Wang, J. Gene;
    • Lich, John;
    • Finger, Joshua;
    • Verticelli, Adeline;
    • Reilly, Michael;
    • Gough, Peter J.;
    • Harris, Philip A.;
    • Bertin, John;
    • Wang, Mei‐Lun
    Publication type:
    Article
    11

    MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses.

    Published in:
    PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0127083
    By:
    • Yu, Jong W.;
    • Hoffman, Sandy;
    • Beal, Allison M.;
    • Dykon, Angela;
    • Ringenberg, Michael A.;
    • Hughes, Anna C.;
    • Dare, Lauren;
    • Anderson, Amber D.;
    • Finger, Joshua;
    • Kasparcova, Viera;
    • Rickard, David;
    • Berger, Scott B.;
    • Ramanjulu, Joshi;
    • Emery, John G.;
    • Gough, Peter J.;
    • Bertin, John;
    • Foley, Kevin P.
    Publication type:
    Article
    12
    13
    14

    Identification of Benzimidazole Diamides as Selective Inhibitors of the Nucleotide-Binding Oligomerization Domain 2 (NOD2) Signaling Pathway.

    Published in:
    PLoS ONE, 2013, v. 8, n. 8, p. 1, doi. 10.1371/journal.pone.0069619
    By:
    • Rickard, David J.;
    • Sehon, Clark A.;
    • Kasparcova, Viera;
    • Kallal, Lorena A.;
    • Zeng, Xin;
    • Montoute, Monica N.;
    • Chordia, Tushar;
    • Poore, Derek D.;
    • Li, Hu;
    • Wu, Zining;
    • Eidam, Patrick M.;
    • Haile, Pamela A.;
    • Yu, Jong;
    • Emery, John G.;
    • Marquis, Robert W.;
    • Gough, Peter J.;
    • Bertin, John
    Publication type:
    Article
    15
    16
    17
    18